Lead discovery from nature, using chemoinformatic and chemometric approaches and traditional knowledge.
Vice-President since 2018; member of the GA Board (2011-); member of the GA YRW (2009-15); Editorial board member of Frontiers in Pharmacol. (2016-18); Editorial board member of Planta Medica (2016-19)
To strengthen the impact and international visibility of our Society in all fields of natural product research and to foster the interaction between academia, industry and stakeholders.
To share the enthusiasm in working with natural products and to encourage primarily young researchers of the GA to work in an open-minded and interdisciplinary way.
Prof. Dr. Anna Rita Bilia
Department of Chemistry "Ugo Schiff"
Via Ugo Schiff 6I - 50019 Sesto Fiorentino (FI), Italy
Analysis and quality control of botanical products. Pharmaceutical technology and innovative nanoformulations of plant extracts and natural constituents.
President of GA. Vice-president of GA from 2013 to 2015. Co-chair of the GA YRW and board member from 2005 to 2013. Italian delegate of the ESCOP BoD and Scientific Committee. Ph. Eur. expert of TCM group.
Promote the diffusion of the scientific and practical knowledge regarding all fields of medicinal plants and natural products. Cooperate with other National, European and extra-European scientific organizations pursuing similar aims. Stimulate and support young scientists researches and networkings.
Prof. Michael Heinrich
The School of Pharmacy, University of London
Centre for Pharmacognosy and Phytotherapy
29 - 39 Brunswick Square
London WC1N 1AX, U.K.
Ethnopharmacology (Europe, México), traditional medical knowledge, anti-inflam-matory natural products, value chains, metabolomics in medicinal plant research
Board Member since 2007, member of GA since 1987, Past President – Internat. Soc. Ethnopharmacology, Spec. Ed in Chief . Frontiers Ethnopharmacol; Reviews’ Ed. - J. Ethnopharmacol., Co-Chair UCL Research Ethics Comm.
Science is a truly global opportunity. However, we face tremendous challenges in all aspect of our societies. Science and technology incl. research on natural products and medicinal plants offers new solutions. The GA is in a unique and strong position to foster international and trans-discip-linary collaboration. I want to strengthen this at all levels and ascertain that the GA’s voice also reaches more stakeholders.
Dr. Bernd Roether
Division Head Drug Regulatory Affairs
Kerschensteiner Str. 11-15
D-92318 Neumarkt, Germany
Drug regulatory affairs of herbal medicinal products and natural products
Member of GA / DPhG / DGRA, former Treasurer of GALecturer at the Rheinische Friedrich-Wilhelms University, Bonn (DGRA Master Study Course, Module 4)
to support establishment of phytotherapy as a standard in allopathy; to support establishment of all regulatory routes necessary to make herbal medicinal products available to patients and consumers; to promote the reputation of GA as an international scientific organization of competence in natural product and medicinal plant research.
Dr. Olaf Kelber
Research and Development Phytomedicines
Bayer Consumer Health, Darmstadt, Germany
Steigerwald Arzneimittelwerk GmbH
Research and development on herbal medicinal products and natural products (pharmacology, toxicology, clinics, quality)
Board member of GA and GPT / Member of ABC / Editorial Board member of journals Phytomedicine, Synergy / Working group on science of Kooperation Phytopharmaka GbR, Bonn, Germany
Medicinal plants and natural products are tremendously gaining importance as a sustainable resource for a better life worldwide. GA is the leading international society to foster scientific exchange and networking in this field, and to advocate for attractive conditions for research and develop-ment and for supportive and effective regulatory frames.